Vivex Biomedical, Inc.
Innovative allografts for surgical and therapeutic applications
- Sector
- Medtech
- Headquarters
- ATLANTA, GA
- Founded
- 2012
- Latest Form D
- $5M offered, Jan 2017
- Total capital
- $8.8M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $8.8M
- 3 Form D · last Jan 2017
- 117 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 36
- 4 pending · first 2015
- Rank in peer group#2 of 50
Capital timeline
Latest events
- Offering registeredForm D · SEC · 3rd filing$5M
- Private capital raisedForm D · SEC · 2nd filing$6.6M
- Private capital raisedForm D · SEC · 1st filing$2.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 50 peers
Line = medianMedtech · Material
- Granted patents#2 · top 4%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Barry J. SalzmanDirectorNamed in SEC Form D filings
- David R. GreenbergDirectorNamed in SEC Form D filings
- Dr. H Thomas TempleExecutive OfficerNamed in SEC Form D filings
- Dr. H. Thomas TempleExecutive OfficerNamed in SEC Form D filings
- Holly S. MasonExecutive OfficerNamed in SEC Form D filings
- H. Thomas TempleDirectorNamed in SEC Form D filings
Show all 25 people
- James K. PriceDirectorNamed in SEC Form D filings
- Jeffrey A. SmithDirectorNamed in SEC Form D filings
- J. Miguel Fernandez de CastroDirectorNamed in SEC Form D filings
- John MarshExecutive OfficerNamed in SEC Form D filings
- John Bertram McCallumDirectorNamed in SEC Form D filings
- Jouko R. RissanenDirectorNamed in SEC Form D filings
- Leo S. CookExecutive OfficerNamed in SEC Form D filings
- Michael RozmajzlExecutive OfficerNamed in SEC Form D filings
- Ricardo J. NunezExecutive OfficerNamed in SEC Form D filings
- Richard E. PerlmanDirectorNamed in SEC Form D filings
- Saadiq Thomas El-Amin, IIIDirectorNamed in SEC Form D filings
- Stuart J KomenskiExecutive OfficerNamed in SEC Form D filings
- Thomas J. GibsonExecutive OfficerNamed in SEC Form D filings
- Thomas A. GreeneDirectorNamed in SEC Form D filings
- Timothy J. Ganey, Ph.D.Executive OfficerNamed in SEC Form D filings
- Timothy LusbyDirectorNamed in SEC Form D filings
- Timothy TaylorDirectorNamed in SEC Form D filings
- Tracy S. AndersonExecutive Officer, DirectorNamed in SEC Form D filings
- U. Bertram Ellis, Jr.DirectorNamed in SEC Form D filings
What it has protected
USPTO · 36 granted of 40- GrantedLiquid Amnion Transplant ProductUSPTOUS 10,842,825
- GrantedAcellular Biologic Composition And Method Of ManufactureUSPTOUS 10,760,058
- GrantedFenestrated Bone GraftUSPTOUS 10,743,994
Show all 40 patent records
- Liquid Amnion Transplant ProductNov 24, 2020 · US 10,842,825Granted
- Acellular Biologic Composition And Method Of ManufactureSep 1, 2020 · US 10,760,058Granted
- Fenestrated Bone GraftAug 18, 2020 · US 10,743,994Granted
- Fenestrated Bone Wrap GraftJun 16, 2020 · US 10,682,440Granted
- Malleable Demineralized Bone Composition And Method Of ManufactureMar 24, 2020 · US 10,596,298Granted
- Biologic Composition And Method Of ManufactureDec 24, 2019 · US 10,513,690Granted
- Moldable Bone CompositionNov 5, 2019 · US 10,463,767Granted
- Bone Induction System And MethodsOct 8, 2019 · US 10,434,217Granted
- Umbilical Cord Transplant ProductSep 17, 2019 · US 10,413,635Granted
- Liquid Amnion Transplant ProductSep 17, 2019 · US 10,413,572Granted
- Bone Growth Enhancing ImplantAug 20, 2019 · US 10,383,740Granted
- Malleable Demineralized Bone Composition And Method Of ManufactureJul 23, 2019 · US 10,357,593Granted
- Fenestrated Bone GraftApr 2, 2019 · US 10,245,146Granted
- Spinal Disc Regenerative Composition And Method Of Manufacture And UseMar 26, 2019 · US 10,238,693Granted
- Spinal Disc Regenerative Composition And Method Of Manufacture And UseMar 5, 2019 · US 10,220,058Granted
- Vertebral Body End-plate Microparticulate Composition And Uses ThereofDec 4, 2018 · US 10,143,562Granted
- Cohesive Bone CompositionNov 13, 2018 · US 10,123,876Granted
- Spinal Disc Regenerative Composition And Method Of Manufacture And UseOct 30, 2018 · US 10,111,908Granted
- Spinal Disc Regenerative Composition And Method Of Manufacture And UseSep 4, 2018 · US 10,064,896Granted
- Bone GraftAug 14, 2018 · US 10,046,089Granted
- Spinal Implants With Stem CellsNov 14, 2017 · US 9,814,558Granted
- Cohesive Bone CompositionOct 17, 2017 · US 9,788,950Granted
- Spinal Implants With Stem CellsSep 12, 2017 · US 9,757,223Granted
- Self-assembly Of Collagen Fibers From Dermis, Fascia And Tendon For Tissue Augmentation And Coverage Of Wounds And BurnsAug 22, 2017 · US 9,737,590Granted
- Tasseled Bone GraftJul 4, 2017 · US 9,693,866Granted
- Acellular Biologic Composition And Method Of ManufactureJun 27, 2017 · US 9,687,511Granted
- Fenestrated Bone Wrap GraftJun 27, 2017 · US 9,687,587Granted
- Biologic Composition And Method Of ManufactureJun 13, 2017 · US 9,675,643Granted
- Biologic Composition And Method Of ManufactureJun 13, 2017 · US 9,675,644Granted
- Spinal Disc Regenerative Composition And Method Of Manufacture And UseMay 23, 2017 · US 9,655,929Granted
- Spinal Disc Regenerative Composition And Method Of Manufacture And UseMay 23, 2017 · US 9,655,928Granted
- Structurally Enhanced Tissue GraftMar 30, 2017 · Application 14865798Pending
- Placental Tissue AssemblyMar 28, 2017 · US 9,603,967Granted
- Shaped Umbilical Cord Transplant ProductFeb 23, 2017 · Application 14851964Pending
- Treated Neural Tissue CompositionAug 2, 2016 · US 9,402,869Granted
- Bone GraftDec 15, 2015 · US 9,211,360Granted
- Dynamic Biometric MeshDec 10, 2015 · Application 14730723Pending
- Bone Screw FastenerNov 10, 2015 · US 9,179,954Granted
- Composition And Method Of Preparation Of Bone Allograft From Endosteal Portion Of Bone And Isolated Bone PeriosteumSep 17, 2015 · Application 14697918Pending
- Fenestrated Bone GraftJun 9, 2015 · US 9,050,111Granted
Related companies, and why
- S4 Medical Corp.Similar federal contract value in Medtech · null in contracts
- LeukoDx, Inc.Similar federal contract value in Medtech · null in contracts
- CURE PHARMACEUTICAL CorpSimilar federal contract value in Medtech · null in contracts
- SCIENTIFIC INTAKE LTD COSimilar federal contract value in Medtech · null in contracts
- NOCIRA, LLCSimilar federal contract value in Medtech · null in contracts
- Fount Bio, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .